In cancer, numerous lines of evidences suggest Prom1high cancer stem cells are resistant to radio‐ and chemo‐therapies and Prom1 neutralizing antibodies or targeted toxin have anti‐tumor activity through unclear mechanism (Damek‐Poprawa et al, 2011; Waldron et al, 2011). This evidence concerns the gene PROM1 and cancer.